Clinical Trial Update: Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing bempedoic acid 180 mg film-coated tablets with Nilemdo 180 mg film-coated tablets has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)
• Nilemdo (bempedoic acid)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Hypercholesterolaemia | Phase 1 | Status: COMPLETED